These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31789481)

  • 1. Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Radhoe SP; Schuurman AS; Ligthart JM; Witberg K; de Jaegere PPT; van Domburg RT; Regar E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E204-E212. PubMed ID: 31789481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
    Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
    EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.
    Varghese MJ; Bhatheja S; Baber U; Kezbor S; Chincholi A; Chamaria S; Buckstein M; Bakst R; Kini A; Sharma S
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e006832. PubMed ID: 30354630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of brachytherapy treatment for coronary in-stent restenosis: Ten-year follow-up.
    Nakahama H; Jankowski M; Dixon SR; Abbas AE
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):E211-E216. PubMed ID: 30280480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer.
    Liang JJ; Sio TT; Slusser JP; Lennon RJ; Miller RC; Sandhu G; Prasad A
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1412-20. PubMed ID: 25459527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Plitt A; Claessen BE; Sartori S; Baber U; Chandrasekhar J; Aquino M; Vijay P; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Krishnan P; Demopoulos A; Dangas G; Kini AS; Mehran R; Sharma SK
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):558-564. PubMed ID: 31490029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes after intravascular brachytherapy for instent restenosis and de novo coronary artery lesions in percutaneous coronary intervention.
    Ho HH; Kwok OH; Jim MH; Siu CW; Pong V; Chow WH
    Cardiovasc Revasc Med; 2011; 12(3):152-157. PubMed ID: 21640933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.